Anthelminthic Agents

Praziquantel, a pyrazinoisoquinoline drug, enters the tegumental cells of parasites and triggers rapid calcium ion influx through ion channels. This causes sustained muscle contraction, leading to paralysis. The disruption makes the tegument porous, exposing internal antigens to the host immune system, which then attacks the weakened parasite.

Host immune modulators, such as antibodies, recognize exposed parasite antigens after anthelmintic drugs damage the parasite's protective structures. This immune response acts synergistically with anthelmintic agents, accelerating parasite clearance. The combination of drug-induced morphological changes and immune attack enhances therapeutic efficacy significantly.

Benzimidazoles such as albendazole and mebendazole impair tubulin polymerization, disrupting microtubule function in parasites. This compromises their motility, energy metabolism, and reproductive processes. These broad-spectrum agents are effective against intestinal nematodes, cestodes, and certain flukes, making them valuable in mass drug administration programs.

Anthelmintics target mature, nonproliferative helminths, whereas antiprotozoal agents typically act on proliferating protozoal cells. Anthelmintics exploit helminth vulnerabilities in neuromuscular coordination, glucose metabolism, and microtubular integrity. This fundamental difference in parasite biology requires tailored therapeutic strategies for each pathogen type.

Ivermectin, an avermectin, targets chloride channels in nematode muscle cells, causing hyperpolarization and paralysis. This mechanism is effective against intestinal nematodes and filariae, notably reducing microfilarial loads in onchocerciasis. The drug's action on ion channels disrupts normal neuromuscular function and host localization.

Niclosamide, a phenolic compound, uncouples oxidative phosphorylation in cestodes, depleting ATP stores and immobilizing the parasite. This mitochondrial disruption strategy targets the parasite's energy production, rendering it unable to survive or reproduce within the host. Secondary agents like oxamniquine and metrifonate use similar energy-depletion approaches.

Pyrantel pamoate, a tetrahydropyrimidine, induces depolarization of nematode muscle cells by activating cholinergic receptors, leading to paralysis and expulsion from the host. Diethylcarbamazine, a piperazine derivative, immobilizes microfilariae through altered arachidonic acid metabolism and enhanced immune clearance, making both effective neuromuscular blockers.